Abstract
Based on a mathematical approach, we deduce a set of triplet homologies that may be responsible for receptor–receptor interactions. We show how such triplets of amino acid residues and their 'teams' may be utilized to construct a kind of code that determines (and/or predicts) which receptors should or should not form heterodimers. Based on the obtained results, we propose a 'guide-and-clasp' manner for receptor–receptor interactions where 'adhesive guides' might be the triplet homologies. We also demonstrate their relevance to protein–protein interactions and mention possible implications for novel pharmacological targets and strategies for treatment of diseases, e.g. neuroinflammatory diseases.
Similar content being viewed by others
References
AbdAlla S, Lother H, el Massiery A, Quitterer U (2001) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7:1003–1009
Adamian L, Jackups R, Binkowski A, Liang J (2003) Higher-order interhelical spatial interactions in membrane proteins. J Mol Bio 327:251–272
Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurone. Pharmacol Rev 55:509–550
Agnati LF, Tarakanov AO, Ferré S, Fuxe K, Guidolin D (2005) Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development. J Mol Neurosci 26(2–3):193–208
Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801
Ayoub MA, Levoye A, Delagrange P, Jockers R (2004) Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol 66:312–321
Baardsnes J, Jelokhani-Niaraki J, Kondejewski LH et al (2001) Antifreeze protein from shorthorn sculpin: identification of the ice-binding surface. Protein Sci 10(12):2566–2576
Baker JG, Hill SJ (2007) Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28:374–381
Bell JK, Botos I, Hall PR et al (2005) The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A 102(31):10976–10980
Block M, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57–69
Canals M, Marcellino D, Fanelli F et al (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278(47):46741–46749
Carriba P, Ortiz O, Patkar K et al (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacol 32(11):2249–2259
Ciruela F, Burqueño J, Casadó V et al (2004) Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem 76(18):5354–5363
Ciruela F, Casadó V, Rodrigues RJ et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A receptor heteromers. J Neurosci 26(7):2080–2087
Dasgupta S, Li XM, Jansson A et al (1996) Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs. Mol Brain Res 36(2):292–299
Díaz-Cabiale Z, Fuxe K, Narváez JA et al (2002) Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist. NeuroReport 13(6):763–766
Doyle CA, Strominger JL (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256–259
El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67:460–469
Ellis J, Pediani JD, Canals M, Milasta S, Milligan G (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J Biol Chem 281(50):38812–38824
Fanelli F (2007) Dimerization of the lutropin receptor: insights from computational modeling. Mol Cell Endocrinol 260–262:59–64
Fereiro DU, Walczak AM, Komives EA, Wolynes PG (2008) The energy landscapes of repeat-containing proteins: topology, cooperativity, and the folding funnels of one-domensional architectures. PLoS Compt Biol 4(5):e1000070
Ferré S, Karcz-Kubicha M, Hope BT et al (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A 99(18):11940–11945
Franco R, Casadó V, Cortéz A et al (2008) Novel pharmacological targets based on receptor heteromers. Brain Res Rev 58(2):475–482
Fuxe K, Ferré S, Zoli M, Agnati LF (1998) Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Rev 26:258–273
Fuxe K, Canals M, Torvinen M et al (2007) Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm 114(1):49–75
Fuxe K, Marcellino D, Rivera A et al (2008a) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 58(2):415–452
Fuxe KG, Tarakanov AO, Goncharova LB, Agnati LF (2008b) A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 58(2):453–458
Gandia J, Galino J, Amaral OB et al (2008) Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique. FEBS Lett 582(20):2979–2984
Gao GF, Tormo J, Gerth UC et al (1997) Crystal structure of the complex between human CD8alpha and HLA-A2. Nature 387(6633):630–634
Gay NJ, Gangloff M, Weber AN (2006) Toll-like receptors as molecular switches. Nat Rev Immunol 6(9):693–698
Gilchrist A (2007) Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci 28:431–437
Ginés S, Hillion J, Torvinen M et al (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A 97(15):8606–8611
Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110
Goncharova LB, Tarakanov AO (2008a) Nanotubes at neural and immune synapses. Curr Med Chem 15(3):210–218
Goncharova LB, Tarakanov AO (2008b) Why chemokines are cytokines while their receptors are not cytokine ones? Curr Med Chem 15(13):1297–1304
Gonzalez-Maeso J, Ang RL, Yuen T et al (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93–97
Goodey NM, Benkovic SJ (2008) Allosteric regulation and catalysis emerge via a common route. Nat Chem Biol 4:474–482
Guo W, Shi L, Filizola M, Weinstein H, Javitch JA (2005) From the cover: crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A 102(48):17495–17500
Guo W, Urizar E, Kravilkova M et al (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 27(17):2293–2304
Gurevich VV, Gurevich EV (2008) How and why do GPCRs dimerize? Trends Pharmacol Sci 29:234–240
Guyon A, Nahon JL (2007) Multiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity. J Mol Endocrinol 38:365–376
Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, Minneman KP (2006) Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Mol Pharmacol 69(1):45–55
Hillion J, Canals M, Torvinen M et al (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091–18097
Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Wilson TA (1996) Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 96:497–501
Hirono M, Yoshioka T, Konishi S (2001) GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat Neurosci 4:1207–1216
Jin MS, Kim SE, Heo JY et al (2007) Crystal structure of the TL1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071–1082
Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697–700
Kamiya T, Saitoh O, Yoshioka K, Nakata H (2003) Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. Biochem Biophys Res Commun 306(2):544–549
Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67(5):1697–1704
Kenakin T (2007) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407–415
Kohl A, Binz HK, Forrer P, Stumpp MT, Plückthun A, Grütter MG (2003) Designed to be stable: crystal structure of a consensus ankyrin repeat protein. Proc Natl Acad Sci U S A 100(4):1700–1705
König R, Zhou Y, Elleder D et al (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135:49–60
Kuner R, Köhr G, Grünewald S, Eisenhardt G, Bach A, Kornau HC (1999) Role of heteromer formation in GABAB receptor function. Science 283:74–77
Lee SP, So CH, Rashid AJ et al (2004) Dopamine D1 and D2 receptor co-activation generanks a novel phospholipase C-mediated calcium signal. J Biol Chem 279(34):35671–35678
Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB (2000) Direct protein-protein coupling enables cross-talk between dopamine D5 and g-aminobutyric acid A receptors. Nature 403:274–280
Lopez-Gimenez JF, Canals M, Pediani JD, Milligan G (2007) The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71(4):1015–1029
Marcellino D, Ferré S, Casadó V et al (2008a) Identification of dopamine D1–D3 receptor heteromers. Indications for a role of synergistic D1–D3 receptor interactions in the striatum. J Biol Chem 283:26016–26025
Marcellino D, Carriba P, Filip M et al (2008b) Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmac 54(5):815–823
Marshall FH, Jones KA, Kaupmann K, Bettler B (2001) GABAB receptors—the first 7TM heterodimers. Trends Pharmacol Sci 20(10):396–399
Matsushima N, Tanaka T, Enkhbayar P et al (2007) Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 8:124–145
Milligan G (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol 153:S216–S229
Mizuno T, Zhang G, Takeuchi H et al (2008) Interferon-γ directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-γ receptor and AMPA GluR1 receptor. FASEB J 22:1797–1806
Moran MF, Koch CA, Sadowski I, Pawson T (1988) Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity. Oncogene 3(6):665–672
NCBI (2009) National center for biotechnology information (http://www.ncbi.nlm.nih.gov).
Percherancier Y, Berchiche A, Slight I et al (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 280(11):9895–9903
Pfeiffer M, Kirscht S, Stumm R et al (2003) Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278(51):51630–51637
Pin JP, Neubig R, Bouvier M et al (2007) International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and Nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 59:5–13
Popoli P, Pèzzola A, Torvinen M et al (2001) The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacol 25(4):505–513
Rashid AJ, So CH, Kong MM et al (2007) D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104(2):654–659
Rios C, Gomes I, Devi LA (2006) Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148(4):387–395
Rocheville M, Lange DC, Kumar U, Patel SC, Patel YC (2000a) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154–157
Rocheville M, Lange DC, Kumar U, Sasi R, Patel SC, Patel YC (2000b) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862–7869
Scarselli M, Novi F, Schallmach E et al (2001) D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 276(32):30308–303014
Suzuki S, Chuang LF, Yau P, Doi RH, Chuang RY (2002) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res 280(2):192–200
Szidonya L, Cserzo M, Hunyady L (2008) Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J Endocrinol 196:435–453
Tarakanov A, Prokaev A (2007) Identification of cellular automata by immunocomputing. J Cell Autom 2(1):39–45
Tarakanov AO, Goncharova LB (2009) Cell-cell nanotubes: Tunneling through several types of synapses. Commun Integr Biol 2(4):359–361
Tarakanov AO, Fuxe KG, Agnati LF, Goncharova LB (2009) Possible role of receptor heteromers in multiple sclerosis. J Neural Transmis 116:989–994
Tobin AB, Butcher AJ, Kong KC (2008) Location, location, location... site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 29(8):413–420
Torvinen M, Marcellino D, Canals M et al (2005) Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Mol Pharmacol 67(2):400–407
von Euler G (1991) Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain. Brain Res 561:93–98
Wang JH, Meijers R, Xiong Y et al (2001) Crystal structure of the human CD4 N-terminal two-domain fragments complexed to a class II MHC molecule. Proc Natl Acad Sci U S A 98(19):10799–10804
Woods AS, Ferré S (2005) Amazing stability of the arginine-phosphate electrostatic interaction. Proteome Res 4:1397–1402
Woods AS, Marcellino D, Jackson SN et al (2008) How calmodulin interacts with the adenosine A2A and the dopamine D2 receptotrs. J Proteome Res 7(8):3428–3434
Xie Z, Lee SP, O’Dowd BF, George SR (1999) Serotonin 5-HT1B and 5-HT1D receptors from homodimers when expressed alone and heterodimers when coexpressed. FEBS Lett 456:63–67
Yoshioka K, Saitoh O, Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci U S A 98:7617–7622
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarakanov, A.O., Fuxe, K.G. Triplet Puzzle: Homologies of Receptor Heteromers. J Mol Neurosci 41, 294–303 (2010). https://doi.org/10.1007/s12031-009-9313-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-009-9313-5